Skip to main content
Top
Published in: European Journal of Pediatrics 9/2015

01-09-2015 | Original Article

Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort

Authors: Lien De Somer, Marie-Anne Morren, P. C. E. Hissink Muller, Karine Despontin, Katrien Jansen, Lieven Lagae, Carine Wouters

Published in: European Journal of Pediatrics | Issue 9/2015

Login to get access

Abstract

Linear scleroderma en coup the sabre (LSCS), progressive facial hemiatrophy (PFH) and autoimmune encephalitis are distinct clinical entities, although patients with overlapping features have been reported. We performed a multicenter retrospective review of a series of children with LSCS and/or PFH to explore the relation between these entities. The files of 16 children were reviewed, 11 presented with LSCS, 5 with PFH, with time overlapping cutaneous features were seen. Extracutaneous signs were found in both groups. ANA were present in more than 50 % of patients. Almost half of our patients presented with CNS manifestations comprising unilateral headache, migraine and epilepsy with or without abnormalities on MRI. Brain biopsy in one patient was consistent with Rasmussen encephalitis. In two other children, associated autoimmune manifestations were present.
Conclusion: Our patient cohort brings more arguments to consider LSCS and PFH as a single disease entity with LSCS and superficial skin involvement at one end of the spectrum and PFH with involvement of subcutaneous deep tissue at the other end. In both entities, encephalitis can be observed. Our findings of circulating ANA, intradermal lymphocytes and IgG, intrathecal IgG production and clinical improvement with immunosuppressive therapy endorse the concept of a possible common immune-inflammatory pathogenesis.
What is known:
LSCS, PFH and immune-inflammatory encephalitis are distinct clinical entities, but patients with overlapping features have been reported.
What is new:
We present a unique paediatric cohort with LSCS, PFH and/or encephalitis.
We endorse the concept of a common immune-inflammatory disease process.
Literature
2.
go back to reference Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128:454–471CrossRefPubMed Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128:454–471CrossRefPubMed
3.
go back to reference Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, Elger CE (2002) Diagnosis and staging of Rasmussen’s encephalitis by serial MRI and histopathology. Neurology 58:250–257CrossRefPubMed Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, Elger CE (2002) Diagnosis and staging of Rasmussen’s encephalitis by serial MRI and histopathology. Neurology 58:250–257CrossRefPubMed
4.
go back to reference Chiu YE, Vora S, Kwon EK, Maheshwari M (2012) A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings. Pediatr Dermatol 29:738–748PubMedCentralCrossRefPubMed Chiu YE, Vora S, Kwon EK, Maheshwari M (2012) A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings. Pediatr Dermatol 29:738–748PubMedCentralCrossRefPubMed
5.
go back to reference El-Kehdy J, Abbas O, Rubeiz N (2012) A review of Parry-Romberg syndrome. J Am Acad Dermatol 67:769–784CrossRefPubMed El-Kehdy J, Abbas O, Rubeiz N (2012) A review of Parry-Romberg syndrome. J Am Acad Dermatol 67:769–784CrossRefPubMed
6.
go back to reference Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA (2006) Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 117:e132–e136CrossRefPubMed Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA (2006) Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 117:e132–e136CrossRefPubMed
7.
go back to reference Kim SJ, Park YD, Hessler R, Lee MR, Smith JR (2010) Correlation between magnetic resonance imaging and histopathologic grades in Rasmussen syndrome. Pediatr Neurol 42:172–176CrossRefPubMed Kim SJ, Park YD, Hessler R, Lee MR, Smith JR (2010) Correlation between magnetic resonance imaging and histopathologic grades in Rasmussen syndrome. Pediatr Neurol 42:172–176CrossRefPubMed
8.
go back to reference Korkmaz C, Adapinar B, Uysal S (2005) Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J 98:940–942CrossRefPubMed Korkmaz C, Adapinar B, Uysal S (2005) Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J 98:940–942CrossRefPubMed
10.
go back to reference Lehman TJ (1992) The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions? J Rheumatol 19:844–845PubMed Lehman TJ (1992) The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions? J Rheumatol 19:844–845PubMed
11.
go back to reference Li SC et al (2012) Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 64:1175–1185 Li SC et al (2012) Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 64:1175–1185
12.
go back to reference Mazzeo N, Fisher JG, Mayer MH, Mathieu GP (1995) Progressive hemifacial atrophy (Parry-Romberg syndrome). Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:30–35CrossRefPubMed Mazzeo N, Fisher JG, Mayer MH, Mathieu GP (1995) Progressive hemifacial atrophy (Parry-Romberg syndrome). Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:30–35CrossRefPubMed
13.
go back to reference Paprocka J, Jamroz E, Adamek D, Marszal E, Mandera M (2006) Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome. Childs Nerv Syst 22:409–415CrossRefPubMed Paprocka J, Jamroz E, Adamek D, Marszal E, Mandera M (2006) Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome. Childs Nerv Syst 22:409–415CrossRefPubMed
14.
go back to reference Shah JR, Juhasz C, Kupsky WJ, Asano E, Sood S, Fain D, Chugani HT (2003) Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 61:395–397CrossRefPubMed Shah JR, Juhasz C, Kupsky WJ, Asano E, Sood S, Fain D, Chugani HT (2003) Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 61:395–397CrossRefPubMed
15.
go back to reference Sommer A, Gambichler T, Bacharach-Buhles M, von Rothenburg T, Altmeyer P, Kreuter A (2006) Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol 54:227–233CrossRefPubMed Sommer A, Gambichler T, Bacharach-Buhles M, von Rothenburg T, Altmeyer P, Kreuter A (2006) Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol 54:227–233CrossRefPubMed
16.
go back to reference Stone J (2003) Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 61:674–676CrossRefPubMed Stone J (2003) Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 61:674–676CrossRefPubMed
17.
go back to reference Terstegge K, Kunath B, Felber S, Speciali JG, Henkes H, Hosten N (1994) MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. AJNR Am J Neuroradiol 15:145–150PubMed Terstegge K, Kunath B, Felber S, Speciali JG, Henkes H, Hosten N (1994) MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. AJNR Am J Neuroradiol 15:145–150PubMed
18.
go back to reference Tollefson MM, Witman PM (2007) En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 56:257–263CrossRefPubMed Tollefson MM, Witman PM (2007) En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 56:257–263CrossRefPubMed
19.
go back to reference Zannin ME, Martini G, Athreya BH, Russo R, Higgins G, Vittadello F, Alpigiani MG, Alessio M, Paradisi M, Woo P, Zulian F (2007) Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 91:1311–1314PubMedCentralCrossRefPubMed Zannin ME, Martini G, Athreya BH, Russo R, Higgins G, Vittadello F, Alpigiani MG, Alessio M, Paradisi M, Woo P, Zulian F (2007) Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 91:1311–1314PubMedCentralCrossRefPubMed
20.
go back to reference Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, Alessio M, La TF, Podda RA, Gerloni V, Cutrone M, Belloni-Fortina A, Paradisi M, Martino S, Perilongo G (2011) Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 63:1998–2006CrossRefPubMed Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, Alessio M, La TF, Podda RA, Gerloni V, Cutrone M, Belloni-Fortina A, Paradisi M, Martino S, Perilongo G (2011) Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 63:1998–2006CrossRefPubMed
21.
go back to reference Zulian F et al (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873–2881CrossRefPubMed Zulian F et al (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873–2881CrossRefPubMed
22.
go back to reference Zulian F et al (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 45:614–620CrossRef Zulian F et al (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 45:614–620CrossRef
Metadata
Title
Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort
Authors
Lien De Somer
Marie-Anne Morren
P. C. E. Hissink Muller
Karine Despontin
Katrien Jansen
Lieven Lagae
Carine Wouters
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 9/2015
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-015-2532-6

Other articles of this Issue 9/2015

European Journal of Pediatrics 9/2015 Go to the issue